Genotoxicity associated with the use of tyrosine kinase inhibitors in patients with chronic myeloid leukemia
Sign Up to like & getrecommendations! Published in 2018 at "Environmental and Molecular Mutagenesis"
DOI: 10.1002/em.22164
Abstract: Genotoxicity AssociatedWith the Use of Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Pedro Aurio Maia Filho ,* Tarcı sio Paulo de Almeida Filho, Caroline de F atima Aquino Moreina-Nunes, Rommel Rodriguez Burbano, Jos… read more here.
Keywords: kinase inhibitors; inhibitors patients; use tyrosine; patients chronic ... See more keywords
Use of PD-1 inhibitors in patients with end-stage renal disease: safety and clinical outcomes from real-world data
Sign Up to like & getrecommendations! Published in 2022 at "Acta Oncologica"
DOI: 10.1080/0284186x.2022.2127121
Abstract: Jiasheng Wang , Srilatha Dasari, Dina Elantably, Akram Alkrekshi and Yeseong David Kim Department of Hematology and Oncology, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; Department of Internal Medicine, MetroHealth Medical… read more here.
Keywords: inhibitors patients; end stage; patients end; stage renal ... See more keywords
Efficacy and safety of SGLT2 inhibitors in patients with heart failure
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000028636
Abstract: Abstract Background: Heart failure (HF) prognosis without therapy is poor, however introduction of a range of drugs has improved it. We aimed to perform a protocol for systematic review and meta-analysis on the effects and… read more here.
Keywords: safety; inhibitors patients; heart failure; review ... See more keywords
Cardiovascular outcomes associated with prescription of sodium‐glucose co‐transporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with diabetes and chronic kidney disease
Sign Up to like & getrecommendations! Published in 2022 at "Diabetes"
DOI: 10.1111/dom.14657
Abstract: To determine the association with cardiovascular (CV) outcomes of sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors compared with dipeptidyl peptidase‐4 (DPP‐4) inhibitors in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). read more here.
Keywords: dipeptidyl peptidase; chronic kidney; glucose transporter; cardiovascular outcomes ... See more keywords
Incidence of low‐titre factor VIII inhibitors in patients with haemophilia A: meta‐analysis of observational studies
Sign Up to like & getrecommendations! Published in 2017 at "Haemophilia"
DOI: 10.1111/hae.13193
Abstract: A few studies have been focused on low‐titre inhibitors in patients with haemophilia A. Although several putative factors have been implicated in the development of these inhibitors, solid data are still lacking. read more here.
Keywords: incidence low; patients haemophilia; factor viii; inhibitors patients ... See more keywords
Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23052815
Abstract: Kinase inhibitors (KIs) represent a growing class of drugs directed at various protein kinases and used in the treatment of both solid tumors and hematologic malignancies. It is a heterogeneous group of compounds that are… read more here.
Keywords: protein kinase; cardiotoxicity induced; kinase inhibitors; kinase ... See more keywords
Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer’s Disease: A Narrative Review
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Geriatric Medicine and Research"
DOI: 10.4235/agmr.21.0079
Abstract: While acetylcholinesterase inhibitors are used to treat a wide range of patients with Alzheimer’s disease, acetylcholinesterase inhibitor use has also been associated with a variety of cardiovascular complications, including bradycardia and syncope. Herein, we review… read more here.
Keywords: alzheimer disease; cardiovascular complications; acetylcholinesterase inhibitors; inhibitors patients ... See more keywords
Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk
Sign Up to like & getrecommendations! Published in 2018 at "Arquivos Brasileiros de Cardiologia"
DOI: 10.5935/abc.20180133
Abstract: Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk Paulo Eduardo Ballvé Behr,1 Emilio Hideyuki Moriguchi,2,3 Iran Castro,4 Luiz Carlos Bodanese,1 Oscar Pereira Dutra,4 Paulo Ernesto Leães,5 Pedro Pimentel Filho6 Hospital… read more here.
Keywords: porto; pcsk9 inhibitors; indications pcsk9; inhibitors patients ... See more keywords
Recommendations for use of ezetimibe and/or PCSK9 inhibitors in patients with elevated LDL-C
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/j22-0060
Abstract: SOURCE CITATION Hao Q, Aertgeerts B, Guyatt G, et al. PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations. BMJ. 2022;377:e069066. 35508320. read more here.
Keywords: inhibitors patients; use ezetimibe; pcsk9 inhibitors; recommendations use ... See more keywords